Madhav V. Dhodapkar

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Emory Healthcare, Emory University, Emory and Henry College, University of Washington, Fred Hutch Cancer Center, Piedmont Cancer Institute, Winship Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 46 papers. Top paper: “Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial”.

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30354-9

N/A

3.8DataRank · unranked

126 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Sandi Hita +12 more

Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer

JCI Insight(2020)10.1172/jci.insight.129353

N/A

2.2DataRank · unranked

62 citations

Federica Costa, Rituparna Das, Alyssa Duffy, Mehmet Samur, Samuel S. McCachren +17 more

Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial

Nature Cancer(2024)10.1038/s43018-024-00818-w

N/A

0.727DataRank · unranked

20 citations

Alexander M. Lesokhin, Barry Paul, Jonathan L. Kaufman, Matthew J. Pianko, Noa Biran +9 more

Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0018

N/A

0.709DataRank · unranked

112 citations

Adam D. Cohen, Akhilesh Kaushal, Alfred L. Garfall, Renee Julia Manalo, Allison R. Carr +8 more

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0043

N/A

0.538DataRank · unranked

35 citations

Ajay K. Nooka, Allison R. Carr, Katherine E. Pendleton, Benjamin G. Barwick, Renee Julia Manalo +12 more

Race-Dependent Differences in Risk, Genomics, and Epstein–Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2119

N/A

0.456DataRank · unranked

8 citations

Rachael Sexton, Antje Hoering, Frits van Rhee, Bart Barlogie, Robert Z. Orlowski +1 more

Venetoclax ex vivo functional profiling predicts improved progression-free survival

Blood Cancer Journal(2022)10.1038/s41408-022-00710-9

N/A

0.345DataRank · unranked

9 citations

Shannon M. Matulis, Benjamin G. Barwick, R. Devin Bog, Conrad W. Shebelut, Mala Shanmugam +12 more

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)

medRxiv(2024)10.1101/2024.01.24.24301058

N/A

0.165DataRank · unranked

2 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.09.024

N/A

0DataRank · unranked

9 citations

Vikas A. Gupta, Sarah Wyman, Michael Graiser, Jonathan L. Kaufman, Dhwani Almaula +7 more

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Journal of Clinical Oncology(2022)10.1200/jco.21.02257

N/A

0DataRank · unranked

49 citations

Uma Shanmugasundaram, Narayanaiah Cheedarla, Hans Verkerke, Venkata Viswanadh Edara, Rajesh M. Valanparambil +16 more

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Journal of Clinical Oncology(2022)10.1200/jco.21.02986

N/A

0DataRank · unranked

43 citations

Jennifer W. Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai +34 more

Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2022)10.1200/jco.22.00088

N/A

0DataRank · unranked

40 citations

Akil Akhtar, Susanne L. Linderman, Lilin Lai, Victor M. Orellana‐Noia, Rafi Ahmed +20 more

Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0173

N/A

0DataRank · unranked

33 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac171

N/A

0DataRank · unranked

15 citations

Fred R. Hirsch, Lawrence H. Kushi, Wendy N. Nembhard, James M. Crawford, Nicholas J. Mantis +92 more

Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0471

N/A

0DataRank · unranked

7 citations

Akil Akhtar, Lilin Lai, Victor M. Orellana‐Noia, Susanne L. Linderman, Ashley A. McCook‐Veal +21 more

Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern

medRxiv(2022)10.1101/2022.01.03.22268599

N/A

0DataRank · unranked

13 citations

Jennifer W. Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai +34 more

Randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8054

N/A

0DataRank · unranked

4 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Jason Valent +11 more

Rapid, High Throughput, Automated Detection Of SARS-Cov-2 Neutralizing Antibodies Against Native-Like Vaccine And Delta Variant Spike Trimers

Research Square(2022)10.21203/rs.3.rs-1322411/v1

N/A

0DataRank · unranked

1 citations

Hans Verkerke, Sindhu Potlapalli, Kaleb McLendon, Anamika Patel, Filipp Frank +20 more

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers

medRxiv(2022)10.1101/2022.02.01.22270279

N/A

0DataRank · unranked

0 citations

Hans Verkerke, Sindhu Potlapalli, Kaleb McLendon, Anamika Patel, Filipp Frank +20 more

1458 Regulation of neoantigen specific T cell infiltration and spatial tumor immune architecture of myeloma and its premalignant precursors

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1458

N/A

0DataRank · unranked

0 citations

Hope Robinson, David L. Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel S. McCachren +16 more

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

Journal of Clinical Investigation(2023)10.1172/jci167629

N/A

0DataRank · unranked

47 citations

Nancy Villa, David L. Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel S. McCachren +19 more

Role of B cells in immune‐related adverse events following checkpoint blockade

Immunological Reviews(2023)10.1111/imr.13238

N/A

0DataRank · unranked

23 citations

Alyssa Duffy, Madhav V. Dhodapkar, Kavita M. Dhodapkar

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.101983

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +23 more

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies

Blood Advances(2023)10.1182/bloodadvances.2022009475

N/A

0DataRank · unranked

13 citations

Jean L. Koff, Lilin Lai, Victor M. Orellana‐Noia, Minal Surati, Alyssa Leal +12 more

Impact of Black Race on Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma Receiving Bortezomib Induction

JCO Oncology Practice(2023)10.1200/op.22.00781

N/A

0DataRank · unranked

12 citations

Kathryn T. Maples, Kevin Hall, Yuan Liu, Yichun Cao, Nisha S. Joseph +7 more

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers

iScience(2023)10.1016/j.isci.2023.108256

N/A

0DataRank · unranked

7 citations

Hans Verkerke, Sindhu Potlapalli, Kaleb McLendon, Anamika Patel, Filipp Frank +22 more

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer

npj Vaccines(2023)10.1038/s41541-023-00779-8

N/A

0DataRank · unranked

5 citations

Lilin Lai, Margaret A. Johns, Meredith E. Davis-Gardner, Susanne L. Linderman, Tarrant McPherson +18 more

Harnessing Dendritic Cells: Next Frontier for Durable Immune Control in Myeloma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2292

N/A

0DataRank · unranked

2 citations

Madhav V. Dhodapkar

Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

(2023)10.1158/2643-3230.c.6551220

N/A

0DataRank · unranked

0 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.17.553767

N/A

0DataRank · unranked

0 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

Research Square(2023)10.21203/rs.3.rs-3293339/v1

N/A

0DataRank · unranked

0 citations

Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis +10 more

TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

Science Immunology(2024)10.1126/sciimmunol.adg1094

N/A

0DataRank · unranked

50 citations

Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S. Ensbey +16 more

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae291

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Immune status and selection of patients for immunotherapy in myeloma: a proposal

Blood Advances(2024)10.1182/bloodadvances.2023011242

N/A

0DataRank · unranked

15 citations

Madhav V. Dhodapkar

Smoldering multiple myeloma: Integrating biology and risk into management

Seminars in Hematology(2024)10.1053/j.seminhematol.2024.10.002

N/A

0DataRank · unranked

2 citations

Elizabeth Hill, Madhav V. Dhodapkar, Roshani Patel

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

npj Vaccines(2024)10.1038/s41541-024-00999-6

N/A

0DataRank · unranked

2 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Immune-aging at diagnosis determines T-cell recovery in childhood leukemia survivors

npj Aging(2025)10.1038/s41514-025-00233-0

N/A

0DataRank · unranked

0 citations

Sharon M. Castellino, Shivani Kapadia, Maryam I. Azeem, Ava Horvat, Taylor Lawrence +3 more

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0205

N/A

0DataRank · unranked

0 citations

William Pilcher, Marina E. Michaud, Chaitanya R. Acharya, Sarthak Satpathy, Edgar Gonzalez‐Kozlova +31 more

Tissue-resident memory-like T cells in tumor immunity: Clinical implications

Seminars in Immunology(2020)10.1016/j.smim.2020.101415

N/A

0DataRank · unranked

25 citations

Kavita M. Dhodapkar, Madhav V. Dhodapkar

Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0177

N/A

0DataRank · unranked

24 citations

Kavita M. Dhodapkar, Rafi Ahmed, Madhav V. Dhodapkar

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high-risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8507

N/A

0DataRank · unranked

26 citations

Sikander Ailawadhi, Rachael Sexton, Antje Hoering, Brea Lipe, Sandi Hita +9 more

Oncolytic virus pelareorep plus carfilzomib phase I trial in carfilzomib-refractory patients (NCI 9603): Responses with cytokine storm.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8535

N/A

0DataRank · unranked

1 citations

Domenico Viola, Ada Donà, Ajay K. Nooka, Jonathan L. Kaufman, Sagar Lonial +6 more

Game of Bones: How Myeloma Manipulates Its Microenvironment

Frontiers in Oncology(2021)10.3389/fonc.2020.625199

N/A

0DataRank · unranked

47 citations

Nisha S. Joseph, Madhav V. Dhodapkar, Kelvin P. Lee, Lawrence Boise, Tyler Moser-Katz

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention

Frontiers in Immunology(2021)10.3389/fimmu.2021.632564

N/A

0DataRank · unranked

18 citations

Kavita M. Dhodapkar, Madhav V. Dhodapkar, Samuel S. McCachren